Medtronic gains FDA OK for heart resynchronization device

05/7/2013 | Bloomberg Businessweek

The FDA has granted Medtronic approval to market its Viva system, an implantable device used to treat heart failure by resynchronizing the beating of a patient's heart. Patients who received the device saw 21% reduced hospitalizations during the first year of implantation compared with those using traditional systems, a company official said.

View Full Article in:

Bloomberg Businessweek

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC